Japanese living donor liver transplantation criteria for hepatocellular carcinoma: nationwide cohort study
Masahiro Ohira,Gaku Aoki,Yasushi Orihashi,Kenichi Yoshimura,Takeo Toshima,Etsuro Hatano,Susumu Eguchi,Taizo Hibi,Kiyoshi Hasegawa,Yuzo Umeda,Takuya Hashimoto,Yasushi Hasegawa,Shuji Nobori,Yasuhiro Ogura,Hiroyuki Nitta,Hiroto Egawa,Hidetoshi Eguchi,Yasutsugu Takada,Yoshihide Ueda,Mureo Kasahara,Shigeyuki Kawachi,Yuji Soejima,Katsutoshi Tokushige,Hiroaki Nagano,Hironori Haga,Takumi Fukumoto,Satoshi Mochida,Koji Umeshita,Hideki Ohdan,Japanese Liver Transplantation Society,Shugo Mizuno,Satoshi Kuboki,Masayuki Otsuka,Takashi Kobayashi,Toshifumi Wakai,Teruhide Ishigame,Shigeru Marubashi,Masaaki Watanabe,Akinobu Taketomi,Shinichi Nakamuma,Shintaro Yagi,Taichi Wakiya,Keinosuke Ishido,Yu Sawada,Itaru Endo,Yuichi Goto,Toru Hisaka,Kenji Uryuhara,Yasunari Sakuma,Hirofumi Ichida,Akio Saiura,Koichiro Haruki,Toru Ikegami,Yukihiro Iso,Taku Aoki,Takeshi Takahara,Hideki Yokoo,Yoshifumi Beck,Shigeto Miyagi,Kazuaki Tokodai
DOI: https://doi.org/10.1093/bjsopen/zrae079
2024-07-02
BJS Open
Abstract:Background: Validating the expanded criteria for living donor liver transplantation for hepatocellular carcinoma using national data is highly significant. The aim of this study was to evaluate the validity of the new Japanese criteria for living donor liver transplantation for hepatocellular carcinoma patients and identify factors associated with a poor prognosis using the Japanese national data set. Methods: The study population comprised patients who underwent living donor liver transplantation for hepatocellular carcinoma at 37 centres in Japan between 2010 and 2018. In a nationwide survey, the overall survival and recurrence-free survival rates were evaluated based on the new Japanese criteria for applying the 5-5-500 rule when extending the indication beyond the Milan criteria. Prognostic factors within the Japanese criteria were determined using the Cox proportional hazards model. Results: Patients within (485 patients) and beyond (31 patients) the Japanese criteria exhibited 5-year overall survival rates of 81% and 58% and 5-year recurrence-free survival rates of 77% and 48% respectively. Patients who met the Milan criteria, but not the 5-5-500 rule, had poorer outcomes. Multivariate analysis for 474 patients identified a neutrophil-to-lymphocyte ratio greater than or equal to 5 and a history of hepatectomy as independent risk factors. Conclusion: This nationwide survey confirms the validity of the Japanese criteria. The poor prognostic factors within the Japanese criteria include a neutrophil-to-lymphocyte ratio greater than or equal to 5 and previous hepatectomy.